The principal objective in establishing a Mental Health Clinical Research Center at NYU is to establish a new organizational structure in the medical school that will enable investigators to work together to improve our understanding and treatment of three major psychiatric illnesses: organic mental syndrome, affective disorders and schizophrenia. Specifically, the Center will be organized in order to: 1) Provide strong and effective leadership in the development of collaborative studies involving clinical investigators and basic scientists. 2) Develop control procedures to insure that only the highest possible quality research is carried out. 3) Provide core resources to investigators in the Center in order to facilitate research design, diagnostic and behavioral assessment, statistical analysis and access to a computer facility. 4) Provide core laboratories to investigators in the Center so that specialized tests and procedures can be carried out in conjunction with clinical and basic science studies. 5) Provide seed money in order to encourage quality pilot proposals, particularly by young investigators. 6) Develop a system for recruitment of normal volunteers, symptomatic volunteers and patient volunteers. 7) Develop both formal and preceptor type training programs for students, postgraduates and other relevant groups, and to provide an institutional frame work for the training and development of young investigators. 8) Establish a Center of excellence in the designated areas of interest of the Center, that will be a resource for the school, the community and the broader scientific community. 9) Organize a system for periodic rigorous external review and criticism in order to maintain the most effective leadership and highest quality of scientific research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH035976-06
Application #
3107045
Study Section
(SRC)
Project Start
1982-02-01
Project End
1988-01-31
Budget Start
1987-02-01
Budget End
1988-01-31
Support Year
6
Fiscal Year
1987
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Kring, A M; Alpert, M; Neale, J M et al. (1994) A multimethod, multichannel assessment of affective flattening in schizophrenia. Psychiatry Res 54:211-22
Serper, M R; Harvey, P D (1994) The need to integrate neuropsychological and experimental schizophrenia research. Schizophr Bull 20:1-11;discussion 13-21
Rosengarten, H; Schweitzer, J W; Friedhoff, A J (1994) Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacol Biochem Behav 49:663-7
Spencer, E K; Alpert, M; Pouget, E R (1994) Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS. Psychopharmacol Bull 30:199-202
Rosengarten, H; Schweitzer, J W; Friedhoff, A J (1993) A mechanism underlying neuroleptic induced oral dyskinesias in rats. Pol J Pharmacol 45:391-8
Franssen, E H; Kluger, A; Torossian, C L et al. (1993) The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline. Arch Neurol 50:1029-39
Silva, R R; Friedhoff, A J; Alpert, M (1993) Neuroleptic withdrawal psychosis in Tourette's disorder. Biol Psychiatry 34:341-2
Thompson, M A; Lee, E; Lawe, D et al. (1992) Nerve growth factor-induced derepression of peripherin gene expression is associated with alterations in proteins binding to a negative regulatory element. Mol Cell Biol 12:2501-13
Wu, J; Filer, D; Friedhoff, A J et al. (1992) Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis. J Biol Chem 267:25754-8
Metz, R; Ziff, E (1991) cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 5:1754-66

Showing the most recent 10 out of 59 publications